These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The prognostic significance of subclinical hepatic encephalopathy. Hartmann IJ; Groeneweg M; Quero JC; Beijeman SJ; de Man RA; Hop WC; Schalm SW Am J Gastroenterol; 2000 Aug; 95(8):2029-34. PubMed ID: 10950053 [TBL] [Abstract][Full Text] [Related]
4. Subclinical hepatic encephalopathy: how best to diagnose? Chalasani N; Gitlin N Am J Gastroenterol; 1997 May; 92(5):905-6. PubMed ID: 9149218 [No Abstract] [Full Text] [Related]
5. [Study on subclinical hepatic encephalopathy in patients with hepatic failure]. Zhang LH; Chong YT; Zhuang P; Zhang WD; Mei YY; Shu X Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):198. PubMed ID: 12716510 [No Abstract] [Full Text] [Related]
6. [Diagnosis and therapy of hepatic encephalopathy]. Held C Z Arztl Fortbild (Jena); 1991 Dec; 85(23):1127-34. PubMed ID: 1685606 [No Abstract] [Full Text] [Related]
7. [Hepatic encephalopathy]. Häussinger D Z Gastroenterol; 2002 Dec; 40 Suppl 2():43-5. PubMed ID: 12467007 [No Abstract] [Full Text] [Related]
10. [Insulin-like growth factor I combining with number connection test for selecting subclinical hepatic encephalopathy]. Wu W; Zhang S; Wu YL; Xi RP Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):486. PubMed ID: 12939183 [No Abstract] [Full Text] [Related]
11. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Quero JC; Hartmann IJ; Meulstee J; Hop WC; Schalm SW Hepatology; 1996 Sep; 24(3):556-60. PubMed ID: 8781324 [TBL] [Abstract][Full Text] [Related]
12. [Hepatic encephalopathy: neuropsychological and neurophysiological diagnosis]. Kuhlbusch R; Enck P; Häussinger D Z Gastroenterol; 1998 Dec; 36(12):1075-83. PubMed ID: 10025059 [TBL] [Abstract][Full Text] [Related]
13. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)]. Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303 [TBL] [Abstract][Full Text] [Related]
14. [Hepatic minimal encephalopathy. The most frequently overlooked, clinically occult "metabolic syndrome" on the cirrhosis patient]. Eisenburg J Fortschr Med; 1996 Apr; 114(12):141-6. PubMed ID: 8682429 [TBL] [Abstract][Full Text] [Related]
15. [Hepatic encephalopathy -- flicker frequency analysis as the focal point for a structured treatment]. Moog G Z Gastroenterol; 2015 Jun; 53(6):611-2. PubMed ID: 26280040 [No Abstract] [Full Text] [Related]
17. Critical flicker frequency: it is time to break down barriers surrounding minimal hepatic encephalopathy. Romero-Gómez M J Hepatol; 2007 Jul; 47(1):10-1. PubMed ID: 17507110 [No Abstract] [Full Text] [Related]
18. Event-related cerebral potentials for the diagnosis of subclinical hepatic encephalopathy in patients with liver cirrhosis. Ciećko-Michalska I; Senderecka M; Szewczyk J; Panasiuk A; Słowik A; Wyczesany M; Binder M; Mach T Adv Med Sci; 2006; 51():273-7. PubMed ID: 17357325 [TBL] [Abstract][Full Text] [Related]
19. Minimal hepatic encephalopathy. Stewart CA; Smith GE Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):677-85. PubMed ID: 18043677 [TBL] [Abstract][Full Text] [Related]